The risk of mortality in patients with coronavirus disease 2019 (COVID-19) is largely related
to an excessive immune response, resulting in a hyperinflammatory and hypercoagulable …

Abstract Background and Objectives Therapeutic plasma exchange (TPE) has been used in
severe COVID‐19 disease to eliminate the cytokine storm. This meta‐analysis aims to …

Background and objectives Cytokine release syndrome in COVID‐19 is due to a
pathological inflammatory response of raised cytokines. Removal of these cytokines by …

The clinical course of COVID-19 may show severe presentation, potentially involving
dynamic cytokine storms and T cell lymphopenia, which are leading causes of death in …

Background Cytokine release syndrome (CRS) significantly contributes to the
pathophysiology and progression of COVID-19. It is speculated that therapeutic plasma …

Objectives To evaluate the safety of therapeutic plasma exchange (TPE) in adult patients
with serious/life-threatening COVID-19 requiring intensive care unit (ICU) admission, and …

ABSTRACT COVID-19 (coronavirus disease 2019), caused by the novel coronavirus SARS-
CoV-2 (severe acute respiratory syndrome coronavirus 2), emerged in Wuhan, China, and …

We conducted this systematic review and meta‐analysis to evaluate the existing evidence
and to quantitatively synthesise evidence on the impact of therapeutic plasma exchange …

Since it was first reported by the China Center for Disease Control and Prevention (China
CDC) in December 2019, multiple mechanisms of pathogenesis have been implied in the …

In the 5 months since initial reports of COVID-19 came to light, the death toll due to SARS-
CoV-2 has rapidly increased. The morbidity and mortality of the infection varies based upon …